Biomarin Pharmaceutical (BMRN) Current Taxes (2010 - 2019)

Biomarin Pharmaceutical's Current Taxes history runs 10 years deep, the most recent figure standing at $11.4 million for Q1 2019.

• Quarterly Current Taxes changed N/A year-over-year to $11.4 million in Q1 2019, while the trailing twelve-month figure through Mar 2019 was $11.4 million (changed N/A YoY) and the FY2018 annual result came in at $7.8 million, down 20.07% from the prior year.
• Current Taxes was $11.4 million for Q1 2019 at Biomarin Pharmaceutical, up from $7.8 million in the prior quarter.
• Across five years, Current Taxes topped out at $11.4 million in Q1 2019 and bottomed at $2.7 million in Q2 2018.
• A 5-year average of $7.9 million and a median of $8.0 million in 2016 frame the typical range for Current Taxes.
• Annual changes were most pronounced in 2015 — Current Taxes surged 132.38% — and 2018, when it sank 69.13%.
• Biomarin Pharmaceutical's Current Taxes stood at $6.4 million in 2015, then climbed by 23.07% to $7.8 million in 2016, then gained by 24.11% to $9.7 million in 2017, then retreated by 20.07% to $7.8 million in 2018, then jumped by 45.81% to $11.4 million in 2019.
• Business Quant data shows BMRN's Current Taxes at $11.4 million in Q1 2019, $7.8 million in Q4 2018, and $2.7 million in Q2 2018.